+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)


Proton Therapy Market - Forecasts from 2018 to 2023

  • ID: 4542601
  • Report
  • 90 pages
  • Knowledge Sourcing Intelligence LLP
until Dec 31st 2019
1 of 3


  • Advanced Oncotherapy plc
  • Hitachi Ltd.
  • Ion Beam Applications SA
  • Mevion Medical Systems
  • ProNova Solutions, LLC
  • ProTon International
  • MORE
The global proton therapy market is anticipated to witness a compound annual growth rate of 4.03% during the forecast period to reach a total market size of US$2.305 billion by 2023, increasing from US$1.819 billion in 2017. The global proton therapy market growth is expected to be driven by a surge in demand from cancer therapy centres. Higher prevalence of cancer has encouraged more clinical research, better clinical understanding and higher patient awareness, which in turn will drive the demand for proton therapy Proton therapy is a highly precise radiation delivering therapeutic procedure for the treatment of cancer and this will boost the growth of the market. The proton therapy market is expected to witness much higher growth on account of rising number of potential candidates for proton therapy. However, High cost of treatment, lack of investment and overlooking of market potential will hamper the market growth over the next year.

This research study examines the current market trends related to the demand, supply, and sales, in addition to the recent developments. Major drivers, restraints, and opportunities have been covered to provide an exhaustive picture of the market. The analysis presents in-depth information regarding the development, trends, and industry policies and regulations implemented in each of the geographical regions. Further, the overall regulatory framework of the market has been exhaustively covered to offer stakeholders a better understanding of the key factors affecting the overall market environment.

Identification of key industry players in the industry and their revenue contribution to the overall business or relevant segment aligned to the study have been covered as a part of competitive intelligence done through extensive secondary research. Various studies and data published by industry associations, analyst reports, investor presentations, press releases and journals among others have been taken into consideration while conducting the secondary research. Both bottom-up and top-down approaches have been utilized to determine the market size of the overall market and key segments. The values obtained are correlated with the primary inputs of the key stakeholders in the proximity sensors value chain. The last step involves complete market engineering which includes analyzing the data from different sources and existing proprietary datasets while using various data triangulation methods for market breakdown and forecasting.

Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining faster and efficient understanding of the market.
Major industry players profiled as part of the report are Mevion Medical Systems, ProNova Solutions, LLC, Proton International, Optivus Proton Therapy, Inc., and Advanced Oncotherapy Plc among others.


The Proton Therapy market has been analyzed through following segments:

By Application:
  • Prostate Cancer
  • Breast Cancer
  • Lung Cancer
  • Paediatric Cancer
  • Others
By Geography:
  • North America
  • United States
  • Canada
  • Others
  • South America
  • Brazil
  • Others
  • Europe
  • United Kingdom
  • Germany
  • France
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Others
  • Asia Pacific
  • Japan
  • China
  • India
  • Others
Note: Product cover images may vary from those shown
2 of 3


  • Advanced Oncotherapy plc
  • Hitachi Ltd.
  • Ion Beam Applications SA
  • Mevion Medical Systems
  • ProNova Solutions, LLC
  • ProTon International
  • MORE
1. Introduction
1.1. Market Definition
1.2. Scope of the Study
1.3. Currency
1.4. Assumptions
1.5. Base, and Forecast Years Timeline

2. Research Methodology
2.1. Research Design
2.2. Secondary Sources
2.3. Validation

3. Key Findings of the Study

4. Market Dynamics
4.1. Drivers
4.2. Restraints
4.3. Opportunities and Market Trends
4.4. Market Segmentation
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Competitive Rivalry in the Industry
4.6. Life Cycle Analysis - Regional Snapshot
4.7. Market Attractiveness

5. Proton Therapy Market Forecast by Application
5.1. Introduction
5.2. Prostate Cancer
5.3. Breast Cancer
5.4. Lung Cancer
5.5. Paediatric Conditions
5.6. Others

6. Proton Therapy Market Forecast by Geography
6.1. North America
5.1.1. United States
5.1.2. Canada
5.1.3. Others
5.2. South America
5.2.1. Brazil
5.2.2. Others
5.3. Europe
5.3.1. United Kingdom
5.3.2. Germany
5.3.3. France
5.3.4. Others
5.4. Middle East and Africa
5.4.1. Saudi Arabia
5.4.2. United Arab Emirates
5.4.3. Others
5.5. Asia Pacific
5.5.1. Japan
5.5.2. China
5.5.3. India
5.5.4. Others

7. Competitive Intelligence
7.1. Market Share Analysis
7.2. Strategies of Key Players
7.3. Recent Investments and Deals

8. Company Profiles
8.1. Introduction
8.2. Hitachi Ltd.
8.2.1. Overview
8.2.2. Financials
8.2.3. Products and Services
8.2.4. Key Developments
8.3. Ion Beam Applications SA
8.3.1. Overview
8.3.2. Financials
8.3.3. Products and Services
8.3.4. Key Developments
8.4. Mevion Medical Systems
8.4.1. Overview
8.4.2. Financials
8.4.3. Products and Services
8.4.4. Key Developments
8.5. Mitsubishi Electric Corporation
8.5.1. Overview
8.5.2. Financials
8.5.3. Products and Services
8.5.4. Key Developments
8.6. ProNova Solutions, LLC
8.6.1. Overview
8.6.2. Financials
8.6.3. Products and Services
8.6.4. Key Developments
8.7. ProTon International
8.7.1. Overview
8.7.2. Financials
8.7.3. Products and Services
8.7.4. Key Developments
8.8. Sumitomo Heavy Industries Ltd.
8.8.1. Overview
8.8.2. Financials
8.8.3. Products and Services
8.8.4. Key Developments
8.9. Varian Medical Systems
8.9.1. Overview
8.9.2. Financials
8.9.3. Products and Services
8.9.4. Key Developments
8.10. Optivus Proton Therapy, Inc.
8.10.1. Overview
8.10.2. Financials
8.10.3. Products and Services
8.10.4. Key Developments
8.11. Advanced Oncotherapy plc
8.11.1. Overview
8.11.2. Financials
8.11.3. Products and Services
8.11.4. Key Developments
8.12. Varian Medical Systems, Inc.
8.12.1. Overview
8.12.2. Financials
8.12.3. Products and Services
8.12.4. Key Developments
List of Tables
List of Figures
Note: Product cover images may vary from those shown
3 of 3


4 of 3
  • Hitachi Ltd.
  • Ion Beam Applications SA
  • Mevion Medical Systems
  • Mitsubishi Electric Corporation
  • ProNova Solutions, LLC
  • ProTon International
  • Sumitomo Heavy Industries Ltd.
  • Varian Medical Systems
  • Optivus Proton Therapy, Inc.
  • Advanced Oncotherapy plc
  • Varian Medical Systems, Inc.
Note: Product cover images may vary from those shown